Blood tests can identify cancer neoantigens for personalized immunotherapy
Cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells, respectively, and they largely matched those found through traditional tumor tissue biopsy in many patients.
Read original article on The Medical News →Related news
-
Researchers suggest tile-based radiation therapy as standard of care to lower risk of recurrence in brain metastases
United Kingdom
-
Exercise may reshape your gut microbiome to support recovery
United Kingdom
-
Tailored ACT+ may address psychological and supportive-care for cancer survivors
United Kingdom
-
Exercise therapy reduces knee osteoarthritis risk after ACL surgery
United Kingdom
-
Norway’s Newest Marine Protected Area Shelters Rich Marine Habitat, Whales, and Seabirds
United Kingdom
-
Fractionated radiosurgery reduces recurrence after surgery for brain metastases, may improve survival
United Kingdom
-
Can’t stop thinking about food? You’re far from alone
United Kingdom
-
Late diagnosis and systemic gaps drive high cancer death rates in the Balkans
United Kingdom